Skip to content

Clinical trials

Phase 2 Granulomatous Disease, Chronic trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Granulomatous Disease, Chronic Phase: Phase 2 Country / region: United States Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20041
20132
20141
20171
20211
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Recruiting2
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Allergy and Infectious Diseases (NIAID)3
Paul Szabolcs2
Baylor College of Medicine1
Medical College of Wisconsin1
Roswell Park Cancer Institute1
Washington University School of Medicine1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Granulomatous Disease, Chronic9
Hyper-IgM Immunodeficiency Syndrome3
Immunologic Deficiency Syndromes3
Lymphohistiocytosis, Hemophagocytic3
Severe Combined Immunodeficiency3
Wiskott-Aldrich Syndrome3
Anemia, Diamond-Blackfan2
Anemia, Sickle Cell2
Autoimmune Lymphoproliferative Syndrome2
Chediak-Higashi Syndrome2

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.